Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access Aug 14, 2025 18:00 HKT/SGT Read More
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration Aug 13, 2025 20:24 HKT/SGT Read More
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance Aug 13, 2025 14:00 HKT/SGT Read More
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision Aug 13, 2025 11:27 HKT/SGT Read More
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products Aug 11, 2025 10:41 HKT/SGT Read More
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan Aug 08, 2025 18:09 HKT/SGT Read More
